Skip to main content
Caplight Logo









Origin Therapy

Origin Therapy

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://origintherapy.com/

Last Round

Series B

Jan 28, 2026

Total Funding Raised

$2.63M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Origin Therapy is a healthtech company that provides a platform for pediatric speech, occupational, and physical therapists to launch and manage their private practices while connecting families with in-home therapy services.

Sector

Healthcare & Life Sciences

Verticals

Telemedicine, Vertical SaaS, Revenue Cycle

Business Model

B2B2C

Customer Profile

Services & Consulting, Subscription SaaS

AI Layer

Application

Keywords

pediatric therapyin-home therapyspeech therapyoccupational therapyphysical therapypractice managementrevenue cycle managementRCMinsurance credentialingvertical SaaShealthtech marketplacepractice-in-a-boxtelemedicineAI-augmented operationspatient engagement

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Origin Therapy Comparables

Compare Origin Therapy with similar companies based on industry and business-model similarity.

Origin Therapy comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Coral Care
88%
Kinspire
75%
Ladder Health
74%

Origin Therapy Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BJan 28, 2026
Pre SeedDec 3, 2025
SeedApr 13, 2021

Key People

Founding team and executive leadership

Gabe Hart

Co-founder CEO

Founding Team

Origin Therapy Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 1, 2026

    Grew 57% QoQ from 7 to 11 employees.

  • Jul 15, 2026

    Grew 43% QoQ from 7 to 10 employees.

Origin Therapy Filings

Explore SEC and related filing metadata, where available.

Origin Therapy filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Origin Therapy's valuation, stock price, and market status.

Is Origin Speech Therapy a public or private company?

Origin Speech Therapy is a private company.

What is the current stock price of Origin Speech Therapy?

Origin Speech Therapy is a private company with no public stock price. No recent secondary market data is available.

How much is Origin Speech Therapy worth (valuation)?

Valuation information for Origin Speech Therapy is not publicly available.

Can I buy Origin Speech Therapy stock?

Origin Speech Therapy shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Origin Speech Therapy's last funding round?

Origin Speech Therapy's most recent funding round was Pre Seed on December 3, 2025.

Who are the main investors in Origin Speech Therapy?

Key investors in Origin Speech Therapy include Distributed Ventures.

Will Origin Speech Therapy IPO soon?

No public IPO plans have been announced for Origin Speech Therapy.

How can I track Origin Speech Therapy secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Origin Speech Therapy's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range11
Year Founded2025
Last FundingJan 28, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?